- Home
- Articles
- latamerica
- preclinical drug development
Preclinical Drug Development Articles & Analysis
11 articles found
Given the complexity of these therapies, specialized services are essential for their advancement. The Importance of Radioactive Drug Conjugate Development Services Radioactive drug conjugate development services focus on the meticulous process of designing, formulating, and producing RDCs. ...
Alfa Cytology unveils advanced PD-1 inhibitor development service for cancer research. Alfa Cytology, a prominent service provider in the oncology landscape, has recently launched its innovative PD-1 inhibitor development services. ...
Alfa Cytology unveils advanced cancer immunotherapy development services. Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. This initiative signifies a major leap forward in the development of more effective cancer therapies, aiming to boost both ...
The evaluation of cardiovascular toxicity is a significant challenge in drug development. Preclinical evaluation of cardiovascular safety involves a multifaceted approach, encompassing a plethora of in vitro and in vivo endpoints. ...
The service encompasses the entire preclinical development lifecycle of therapeutic antibodies—ranging from initial conceptualization and engineering to rigorous quality assurance assessments. ...
Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. Alfa Cytology, a comprehensive biotech company specializing in cancer research, has recently announced the cancer small molecule drug development services. ...
As a leading biotechnology company, MtoZ Biolabs is committed to providing comprehensive, one-stop CRO testing services to scientific research institutions and pharmaceutical companies worldwide. Whether in the early stages of drug discovery, candidate drug evaluation, or preclinical development, MtoZ Biolabs can provide ...
In the world of pharmaceuticals, developing safe and effective drugs is a complex and time-consuming process. ...
Understanding the functional characteristics and cellular tropism of SARS-CoV-2, as well as the pathogenesis leading to multi-organ failure and death, has driven the unprecedented adoption of organoid models. Successful drug discovery and vaccine development rely on preclinical models that faithfully recapitulate the viral life cycle and host ...
Prediction of the first-in-human dosing regimens is a critical step in drug development and requires accurate quantitation of drug distribution. ...
However, these studies can be lengthy and expensive and may not accurately recapitulate the behavior of the human gastrointestinal tract. Drugs are thus often developed with undesired gut side effects that are not apparent until clinical trials. ...